CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 Sarepta Therapeutics, Inc. - SRPT CFD

127.44
0.54%
0.74
最低: 125.88
最高: 128.35
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.74
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Sarepta Therapeutics Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 128.13
开仓* 126.8
1 年变化* 81.43%
日范围* 125.88 - 128.35
52 周范围 61.28-159.89
平均交易量(10 天) 1.49M
平均交易量(3 个月) 34.42M
市值 11.75B
市盈率 -100.00K
流通股 93.15M
收入 975.68M
EPS -12.69
股息(收益率 %) N/A
贝塔 1.01
下一个财报发布日期 Jul 31, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low
Jun 6, 2023 128.13 1.99 1.58% 126.14 130.12 125.42
Jun 5, 2023 125.52 0.20 0.16% 125.32 127.06 124.72
Jun 2, 2023 125.05 -0.34 -0.27% 125.39 126.12 123.42
Jun 1, 2023 123.72 0.23 0.19% 123.49 125.35 121.44
May 31, 2023 123.23 -1.16 -0.93% 124.39 125.49 122.59
May 30, 2023 124.72 -2.16 -1.70% 126.88 127.55 123.89
May 26, 2023 126.70 -1.43 -1.12% 128.13 128.70 125.73
May 25, 2023 128.29 -0.56 -0.43% 128.85 130.79 125.20
May 24, 2023 130.77 -3.49 -2.60% 134.26 138.75 128.06
May 23, 2023 146.34 -0.46 -0.31% 146.80 149.96 146.15
May 22, 2023 148.60 0.51 0.34% 148.09 151.64 148.05
May 19, 2023 148.45 1.54 1.05% 146.91 149.24 145.47
May 18, 2023 146.04 -1.49 -1.01% 147.53 148.58 144.09
May 17, 2023 148.30 -0.15 -0.10% 148.45 149.82 144.53
May 16, 2023 148.31 -4.88 -3.19% 153.19 153.43 147.50
May 15, 2023 155.77 6.59 4.42% 149.18 159.63 146.35
May 11, 2023 119.53 -0.42 -0.35% 119.95 120.23 113.09
May 10, 2023 120.52 -11.25 -8.54% 131.77 134.60 120.52
May 9, 2023 124.84 -0.03 -0.02% 124.87 128.53 124.09
May 8, 2023 126.68 -4.16 -3.18% 130.84 130.84 125.74

Sarepta Therapeutics, Inc. Events

时间(协调世界时) (UTC) 国家/地区 事件
Thursday, June 8, 2023

时间(协调世界时) (UTC)

14:00

国家/地区

US

事件

Sarepta Therapeutics Inc Annual Shareholders Meeting
Sarepta Therapeutics Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, July 31, 2023

时间(协调世界时) (UTC)

10:59

国家/地区

US

事件

Q2 2023 Sarepta Therapeutics Inc Earnings Release
Q2 2023 Sarepta Therapeutics Inc Earnings Release

Forecast

-

Previous

-
Tuesday, October 31, 2023

时间(协调世界时) (UTC)

10:59

国家/地区

US

事件

Q3 2023 Sarepta Therapeutics Inc Earnings Release
Q3 2023 Sarepta Therapeutics Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 933.013 701.887 540.099 380.833 301.034
收入 933.013 701.887 540.099 380.833 301.034
收入成本,共计 139.989 97.049 63.382 56.586 34.193
毛利 793.024 604.838 476.717 324.247 266.841
总营业费用 1597.23 1064.08 996.193 1086.4 644.662
销售/一般/行政费用,总计 451.421 282.66 317.875 284.812 207.761
研究与开发 877.09 771.182 722.343 560.909 401.843
营业收入 -664.217 -362.198 -456.094 -705.563 -343.628
利息收入(费用),非经营净值 -30.06 -55.971 -101.977 -18.982
税前净收入 -689.963 -418.948 -553.065 -713.88 -362.61
税后净收入 -703.488 -418.78 -554.128 -715.075 -361.918
未计算非常项目前的净收益 -703.488 -418.78 -554.128 -715.075 -361.918
净收入 -703.488 -418.78 -554.128 -715.075 -361.918
普通股股东可获收益 (不含非经常性项目) -703.488 -418.78 -554.128 -715.075 -361.918
普通股股东可获收益 (含非經常性項目) -703.488 -418.78 -554.128 -715.075 -361.918
摊薄净收入 -703.488 -418.78 -554.128 -715.075 -361.918
摊薄后加权平均股 87.559 81.262 77.956 73.615 66.25
扣除特别项目的每股摊薄盈利 -8.03445 -5.15345 -7.10821 -9.71371 -5.46291
每股正常摊薄盈利 -7.08411 -5.85345 -8.0093 -7.27209 -5.46291
Depreciation / Amortization 0.714 0.706 0.662 0.849 0.865
异常费用(收入) 128.016 -87.512 -108.069 183.24 0
其他,净值 4.314 -0.779 5.006 -8.317
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
总收入 253.5 258.427 230.269 233.487 210.83
收入 253.5 258.427 230.269 233.487 210.83
收入成本,共计 35.017 30.799 39.952 37.795 31.443
毛利 218.483 227.628 190.317 195.692 179.387
总营业费用 778.917 367.835 487.065 444.619 297.711
销售/一般/行政费用,总计 110.714 120.478 104.787 154.316 71.84
研究与开发 245.679 213.804 216.707 252.329 194.25
Depreciation / Amortization 0.178 0.179 0.178 0.179 0.178
异常费用(收入) 387.329 2.575 125.441 0 0
营业收入 -525.417 -109.408 -256.796 -211.132 -86.881
利息收入(费用),非经营净值 2.953 2.438 -3.256 -13.619 -15.623
其他,净值 9.754 5.664 3.634 -3.342 -1.642
税前净收入 -512.71 -101.306 -256.418 -228.093 -104.146
税后净收入 -516.755 -109.244 -257.738 -231.481 -105.025
未计算非常项目前的净收益 -516.755 -109.244 -257.738 -231.481 -105.025
净收入 -516.755 -109.244 -257.738 -231.481 -105.025
普通股股东可获收益 (不含非经常性项目) -516.755 -109.244 -257.738 -231.481 -105.025
普通股股东可获收益 (含非經常性項目) -516.755 -109.244 -257.738 -231.481 -105.025
摊薄净收入 -516.755 -109.244 -257.738 -231.481 -105.025
摊薄后加权平均股 88.186 87.841 87.628 87.511 87.253
扣除特别项目的每股摊薄盈利 -5.85983 -1.24366 -2.94127 -2.64516 -1.20368
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -3.00491 -1.2246 -2.01079 -2.64516 -1.20368
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 2557.86 2604.1 2485.2 1468.91 1426.18
现金和短期投资 1989.37 2115.87 1938.57 1124.75 1173.91
现金等价物 966.777 2115.87 1502.65 835.08 370.829
短期投资 1022.6 0 435.923 289.668 803.083
应收账款总额,净额 259.697 171.637 138.583 93.938 64.436
Accounts Receivable - Trade, Net 214.628 152.99 101.34 90.879 49.044
Total Inventory 203.968 186.212 231.961 171.379 125.445
Prepaid Expenses 30.645 30.583 37.586 19.323 22.006
Other Current Assets, Total 74.177 99.798 138.495 59.525 40.384
Total Assets 3128.37 3147.97 2984.72 1822.82 1642.07
Property/Plant/Equipment, Total - Net 244.991 236.687 282.191 167.553 97.024
Property/Plant/Equipment, Total - Gross 393.867 349.319 358.218 218.548 125.173
Accumulated Depreciation, Total -148.876 -112.632 -76.027 -50.995 -28.149
Intangibles, Net 7.578 14.239 13.628 12.497 11.574
Other Long Term Assets, Total 286.615 258.057 164.904 141.922 75.555
Total Current Liabilities 619.604 452.733 416.026 264.767 173.69
Accounts Payable 95.875 76.741 111.09 68.094 33.829
Accrued Expenses 353.18 224.601 171.865 148.124 107.648
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0
Other Current Liabilities, Total 170.549 151.391 133.071 48.549 32.213
Total Liabilities 2743.42 2219.97 2222.96 1004.64 609.799
Total Long Term Debt 1544.29 1096.88 992.493 681.9 420.554
Long Term Debt 1544.29 1096.88 992.493 681.9 420.554
Other Liabilities, Total 579.52 670.356 814.44 57.968 15.555
Total Equity 384.95 928.009 761.759 818.187 1032.28
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.009 0.009 0.008 0.008 0.007
Additional Paid-In Capital 4296.84 4134.77 3609.88 3112.13 2611.29
Retained Earnings (Accumulated Deficit) -3910.24 -3206.75 -2848.13 -2294 -1578.93
Other Equity, Total -1.664 -0.02 0.003 0.05 -0.099
Total Liabilities & Shareholders’ Equity 3128.37 3147.97 2984.72 1822.82 1642.07
Total Common Shares Outstanding 87.9501 87.127 79.3743 75.1849 71.0719
Long Term Investments 31.321 34.892 38.799 31.937 31.739
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
流动资产总额 2488.38 2557.86 2625.93 2469.3 2530.95
现金和短期投资 1882.1 1989.37 2072.48 1928.02 2013.43
现金等价物 871.668 966.777 1038.62 868.565 1233.88
短期投资 1010.43 1022.6 1033.86 1059.45 779.548
应收账款总额,净额 288.076 259.697 223.45 230.275 197.201
Accounts Receivable - Trade, Net 223.836 214.628 201.509 203.854 178.194
Total Inventory 202.675 203.968 221.192 208.095 198.997
Prepaid Expenses 28.73 30.645 25.392 23.604 25.766
Other Current Assets, Total 86.799 74.177 83.411 79.307 95.558
Total Assets 3059.79 3128.37 3156.15 2996.85 3056.15
Property/Plant/Equipment, Total - Net 244.878 244.991 224.039 230.291 233.23
Intangibles, Net 7.199 7.578 13.057 13.062 13.328
Long Term Investments 31 31.321 33.244 33.234 33.394
Other Long Term Assets, Total 288.332 286.615 259.88 250.966 245.255
Total Current Liabilities 536.884 619.604 602.916 545.566 454.962
Accounts Payable 106.71 95.875 118.461 56.207 54.007
Accrued Expenses 260.77 353.18 301.056 315.338 224.935
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 169.404 170.549 183.399 174.021 176.02
Total Liabilities 2347.04 2743.42 2725.31 2270.4 2199.27
Total Long Term Debt 1234.28 1544.29 1542.77 1100.87 1098.85
Long Term Debt 1234.28 1544.29 1542.77 1100.87 1098.85
Other Liabilities, Total 575.869 579.52 579.623 623.957 645.459
Total Equity 712.749 384.95 430.84 726.457 856.886
Common Stock 0.009 0.009 0.009 0.009 0.009
Additional Paid-In Capital 5140.15 4296.84 4235.03 4272.19 4168.96
Retained Earnings (Accumulated Deficit) -4426.99 -3910.24 -3800.99 -3543.25 -3311.77
Other Equity, Total -0.419 -1.664 -3.205 -2.485 -0.306
Total Liabilities & Shareholders’ Equity 3059.79 3128.37 3156.15 2996.85 3056.15
Total Common Shares Outstanding 93.1401 87.9501 87.7662 87.5353 87.4956
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -703.488 -418.78 -554.128 -715.075 -361.918
经营活动产生的现金 -325.346 -443.172 107.466 -456.463 -388.66
经营活动产生的现金 41.864 38.017 26.911 30.547 12.245
非现金物品 375.748 35.757 80.627 294.946 68.905
已付现金利息 44.418 55.949 34.418 8.55 11.308
营运资金的变化 -39.47 -98.166 554.056 -66.881 -107.892
投资活动产生的现金 -1046.88 495.413 -121.721 286.725 -370.488
资本支出 -30.824 -38.49 -82.202 -62.713 -64.345
其他投资现金流量项目,总计 -1016.06 533.903 -39.519 349.438 -306.143
融资活动产生的现金 232.507 561.569 682.323 642.554 530.15
股票的发行(报废),净额 -70.945 569.334 396.01 401.955 563.631
债务的发行(退还),净额 304.168 0 291.15 245.625 -33.481
现金净变化 -1139.72 613.81 668.068 472.816 -228.998
Cash Taxes Paid 1.695 0.583 2.51 0.933 1.548
融资现金流项目 -0.716 -7.765 -4.837 -5.026 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -516.755 -703.488 -594.244 -336.506 -105.025
Cash From Operating Activities -209.396 -325.346 -232.954 -167.99 -101.175
Cash From Operating Activities 11.305 41.864 31.311 20.608 10.719
Non-Cash Items 425.11 375.748 318.056 145.971 36.648
Cash Interest Paid 7.023 44.418 41.273 27.78 11.688
Changes in Working Capital -129.056 -39.47 11.923 1.937 -43.517
Cash From Investing Activities 12.492 -1046.88 -1056.68 -1075.8 -785.807
Capital Expenditures -9.485 -30.824 -22.86 -14.629 -5.551
Other Investing Cash Flow Items, Total 21.977 -1016.06 -1033.82 -1061.17 -780.256
Cash From Financing Activities 101.795 232.507 221.758 5.329 4.99
Financing Cash Flow Items -6.887 -0.716 -0.162 0 0
Issuance (Retirement) of Stock, Net 108.682 -70.945 -82.248 5.329 4.99
Net Change in Cash -95.109 -1139.72 -1067.88 -1238.46 -881.992
Issuance (Retirement) of Debt, Net 304.168 304.168
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.693 8097450 79700 2023-03-31 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 5.2692 4908204 -1119812 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.2812 3987871 -30286 2023-03-31 LOW
Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 3.9185 3650000 475000 2023-03-31 LOW
Barry (Richard J) Individual Investor 3.3584 3128319 1430 2023-04-14 LOW
EcoR1 Capital, LLC Hedge Fund 3.2201 2999453 0 2023-03-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 3.1494 2933612 379548 2023-03-31 LOW
JP Morgan Asset Management Investment Advisor 3.1009 2888483 2405135 2023-03-31 LOW
Two Sigma Investments, LP Hedge Fund 2.4401 2272877 971837 2023-03-31 HIGH
Fidelity Management & Research Company LLC Investment Advisor 2.4199 2254083 19413 2023-03-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.9045 1773976 -167768 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3548 1261971 43239 2023-03-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 1.3135 1223537 25601 2023-03-31 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.3026 1213356 282713 2023-03-31 LOW
Casdin Capital, LLC Hedge Fund 1.2453 1160000 -155000 2023-03-31 MED
T. Rowe Price Associates, Inc. Investment Advisor 1.2066 1123923 334496 2023-03-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.0233 953204 270542 2023-03-31 LOW
Farallon Capital Management, L.L.C. Hedge Fund 0.9805 913300 -15600 2023-03-31 MED
DWS Investment GmbH Investment Advisor/Hedge Fund 0.9456 880796 -33023 2023-03-31 LOW
Sands Capital Management, LLC Investment Advisor 0.9391 874765 -1276613 2023-03-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

Sarepta Company profile

关于 Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc.是一家商业阶段的生物制药公司。 公司专注于通过发现和开发用于治疗罕见疾病的核糖核酸(RNA)靶向疗法、基因疗法和其他基因治疗方式来帮助患者。 它正在开发一系列疾病和紊乱的候选治疗药物,包括杜兴氏肌肉萎缩症(Duchenne)、肢体腰部肌肉萎缩症(LGMDs)和其他神经肌肉和中枢神经系统(CNS)疾病。 该公司商业化了三种产品,如EXONDYS 51 (eteplirsen)注射液、VYONDYS 53 (golodirsen)注射液和AMONDYS 45 (casimersen)注射液。 这些商业产品适用于治疗杜氏综合症,这些患者的肌营养蛋白基因确认发生了突变,可以进行51号外显子、53号外显子和45号外显子跳转。 该公司的产品线包括40多个处于不同发现、临床前和临床开发阶段的项目。

Industry: Bio Therapeutic Drugs

215 1st St Ste 415
CAMBRIDGE
MASSACHUSETTS 02142-1213
US

收入报表

  • Annual
  • Quarterly

人们也观看

XRP/USD

0.52 Price
-1.270% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00331

Oil - Crude

72.61 Price
+1.450% 1D Chg, %
多头隔夜费 -0.0156%
空头隔夜费 -0.0063%
隔夜费时间 21:00 (UTC)
价差 0.03

BTC/USD

26,426.70 Price
-2.060% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

US100

14,310.90 Price
-1.780% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 1.8

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易